Merck Wins Another Federal Bellwether Trial Regarding FOSAMAX® (alendronate sodium)
WHITEHOUSE STATION, N.J., Oct. 3, 2011 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today said a federal court jury in New York found in its favor in the Secrest v. Merck case, rejecting the claim of a Florida woman who blamed …